by Samsara@8529 | Sep 21, 2022 | Blog, Home
Insights / News Article Meet Nicole – From Books to Bench Sep 21, 2022 Hear from Nicole Mak, a Biology student at Bath University, on her year in industry with Samsara. Why Samsara? The research role at Samsara aligned perfectly with my passions and skillset. I have... by Samsara@8529 | Jan 5, 2022 | Home, News
News Article Samsara Therapeutics Establishes Scientific Advisory Board Michael Schlossmacher, Susan Perlman, Ed Tate and Christian Behl to help advance development of neurodegeneration and rare genetic disease therapeutics Oxford, UK and Boston, US, 06 January... by Samsara@8529 | Dec 29, 2021 | Home, News
Insights / News Article More additions to the Samsara Therapeutics team Dec 01, 2021 We’re pleased to report that we’ve further strengthened our team in Oxford. Matthew Williamson is an expert in stem cells and patient-derived assays for Parkinson’s Disease, an... by Samsara@8529 | Jul 2, 2021 | Blog, Home
Insights / Blog Neurodegeneration, lysosomal dysfunction and autophagy By John K. Blackwood and Peter Hamley July 02, 2021 There is a desperate need for novel therapies that can prevent the progressive neurodegeneration in debilitating diseases of ageing, such as... by Samsara@8529 | Jun 7, 2021 | Home, News
Insights / News Article New home and strengthening our scientific team June 02, 2021 June 02, 2021 — It’s a busy time for Samsara Therapeutics as we move into our new purpose-built labs and offices in the Wood Centre for Innovation in Oxford. This is a brand new... by Samsara@8529 | Feb 23, 2021 | Blog, Home
Insights / Blog Autophagy, healthspan and lifespan By Sebastian A. Brunemeier | Feb 23, 2021 Our strategy in Samsara is to treat diseases where there is a high unmet need. But we also want to find out how our molecules work to affect healthspan and longevity....